Map: Your state's health care job losses amid Covid-19

Newly released data from the Bureau of Labor Statistics reveals a state-by-state picture of how the coronavirus epidemic has roiled the health care job market. See how many jobs have been lost in your state—broken down by hospitals, ambulatory care, and residential facilities—on our interactive maps.

Read More

US coronavirus cases are spiking. Are deaths about to surge too?

The daily number of newly reported cases of the novel coronavirus in America grew by about 20% over the past two weeks, but growth in the daily number of U.S. deaths linked to the virus hasn't yet followed—and actually declined by about 43% over the past two weeks, data shows.

How AdventHealth revamped clinician onboarding amid Covid-19—without delaying start dates

For many organizations, summer brings large cohorts of new hires—but given restrictions on in-person meetings, this year's onboarding process will look quite different. To learn how one organization launched its virtual onboarding program—without delaying a single start date—Advisory Board's Lauren Rewers and Taylor Hurst spoke to Annette Carter, the regional director of learning within AdventHealth's Central Florida Division, to get her lessons learned from the experience.

Weekly review: Charted: Who's at highest risk of dying from Covid-19?

US News names the "Best Children's Hospitals" of 2020, why some Americans won't wear face masks, and more.

What does it mean if you test positive for coronavirus antibodies? It's complicated.

Millions of people have been tested for antibodies to the novel coronavirus, but researchers say receiving a positive result doesn't mean you should stop taking steps to protect yourself against the virus.

Covid-19 roundup: WHO drops hydroxychloroquine from Covid-19 clinical trial

NIH expands Covid-19 research in underrepresented communities, Gilead Sciences tests remdesivir in pediatric patients, and more.

Around the nation: CMS announces proposal to encourage value-based drug pricing

The proposed rule aims to make it easier for commercial health plans to enter into value-based payment agreements with drugmakers by changing the way Medicaid's so-called "best prices" are calculated, in today's bite-sized hospital and health industry news from the District of Columbia, Maryland, Michigan, and Wisconsin.